Effects of consumption of the test food on walking function in healthy Japanese women aged 50 or more
- Conditions
- Healthy Japanese subjects
- Registration Number
- JPRN-UMIN000045809
- Lead Sponsor
- ORTHOMEDICO Inc.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 19
Not provided
Subjects who 1. are undergoing medical treatment or have a medical history of malignant tumor, heart failure, and myocardial infarction 2. have a pacemaker or an implantable cardioverter defibrillator (ICD) 3. are undergoing or need to undergo treatment for knee disease such as knee osteoarthritis 4. have undergone or need to undergo knee or back surgery 5. may experience rheumatic pain 6. are attending an orthopedic or osteopathic clinic 7. are intensely exercising to make excessive load on the body 8. currently under the treatment for either cardiac arrhythmia, hepatic disorder, renal disorder, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension, bronchial asthma, coagulation disorder, prostate cancer, glaucoma, hypercholesterolemia, gastric ulcer, gout, hemophilia, hypoprothrombinemia, photosensitivity, hemorrhagic disease, convulsive disorder, aspirin sensitivity, vitamin B12 deficiency, psoriasis, hereditary eye disease such as Leber disease, red blood cell abnormality such as megaloblastic anemia or polycythemia vera, or other chronic diseases 9. have high serum calcium levels 10. plan to undergo a surgical operation between two weeks before first consumption and two weeks after last consumption 11. take "Foods for Specified Health Uses," "Foods with Functional Claims," or other functional food/beverage in daily use 12. currently taking medications (including herbal medicines) and supplements 13. are allergic to medicines and/or the test food related products 14. have allergic reactions to nonsteroidal anti-inflammatory drugs, cobalt or cobalamin 15. are pregnant, breast-feeding, and plan to become pregnant after participate in the study 16. suffer from COVID-19 17. have been enrolled in other clinical trials within the last three month before the agreement to participate in this trial or plan to participate another trial during this trial 18. are judged as ineligible to participate in the study by the physician
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method